Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Drug Res (Stuttg) ; 65(8): 393-7, 2015 Aug.
Article in English | MEDLINE | ID: mdl-24782287

ABSTRACT

Neuro-inflammation in Parkinson's disease (PD) is associated with glial cell activation and production of different inflammatory cytokines. In this study we investigated the effect of chronic administration of buspirone and fluoxetine on cerebrospinal fluid (CSF) levels of inflammatory cytokines, TNF-α, IL-1ß and IL-6 in 6-hydroxydopamine (6-OHDA)-lesioned rats.6-OHDA (8 µg/2 µl/rat) was injected unilaterally into the central region of the substantia nigra pars copmacta (SNc) and after 21 days lesioned rats were treated with buspirone and fluoxetine intraperitonealy (i.p.) for 10 days. CSF samples were collected at tenth day of drugs administration and were analysed by ELISA method to measure TNF-α, IL-1ß and IL-6 levels.The results showed that the CSF levels of TNF-α was increased 3 weeks after 6-OHDA injection while there was a significant decrease in TNF-α levels of parkinsonian animals treated with buspirone (1 mg/kg) and fluoxetine (1 mg/kg). IL-1ß and IL-6 both were decreased in parkinsonian rats, while their level was increased in buspirone (1 mg/kg) and fluoxetine (1 mg/kg) treated parkinsonian rats.Our study indicates that chronic administration of buspirone and fluoxetine in 6-OHDA-lesioned rats restores central concentration of inflammatory cytokines to the basal levels. We suggest that serotonergic agents can be used as adjuvant therapy along with commonly used anti-parkinsonian drugs by modulation of cerebral inflammatory cytokines. We suggest that the further clinical investigations may be carried out to prove this hypothesis.


Subject(s)
Buspirone/administration & dosage , Fluoxetine/administration & dosage , Interleukin-1beta/metabolism , Interleukin-6/metabolism , Oxidopamine/administration & dosage , Tumor Necrosis Factor-alpha/metabolism , Animals , Cerebrospinal Fluid/metabolism , Male , Parkinson Disease/drug therapy , Parkinson Disease/metabolism , Parkinsonian Disorders/drug therapy , Parkinsonian Disorders/metabolism , Rats , Rats, Wistar , Substantia Nigra/drug effects , Substantia Nigra/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...